LeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.57%, EPS grew 23.0%, free cash flow fell 28.0% and total debt was flat, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow LMAT
LeMaitre Vascular, Inc. (LMAT) P/E ratio
As of 16 October 2026, LeMaitre Vascular, Inc. (LMAT) trades at a P/E ratio of 27.9×. Over the past ten years it has ranged from 19.0× (January 2019) to 72.6× (June 2023); the current reading is higher than 9% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 31.7× | (32.27%) |
| FY2024 | 46.8× | 11.34% |
| FY2023 | 42.0× | (12.16%) |
| FY2022 | 47.8× | 20.91% |
| FY2021 | 39.6× | 2.54% |
| FY2020 | 38.6× | (3.44%) |
| FY2019 | 39.9× | 99.38% |
| FY2018 | 20.0× | (42.06%) |
| FY2017 | 34.6× | (21.88%) |
| FY2016 | 44.3× | 12.90% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 33.1× | (16.34%) |
| Mar 2026 | 39.6× | 24.86% |
| Dec 2025 | 31.7× | (14.20%) |
| Sep 2025 | 36.9× | (6.63%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| KMTS Kestra Medical Technologies, Ltd. compare | n/m |
| AZTA Azenta, Inc. compare | n/m |
| XRAY DENTSPLY SIRONA Inc. compare | n/m |
| LMAT LeMaitre Vascular, Inc. | 27.9× |
| NVST Envista Holdings Corporation compare | 38.8× |
| ATRC AtriCure, Inc. compare | 259× |
| STAA STAAR Surgical Company compare | 304× |
| WRBY Warby Parker Inc. compare | 334× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)